SMC approves daratumumab for myeloma patients in Scotland

The Scottish Medicines Consortium (SMC) has approved the use of daratumumab (Darzalex) to treat myeloma patients on National Health Service (NHS) Scotland.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news